BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 16341338)

  • 1. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    BMC Infect Dis; 2005 Nov; 5():105. PubMed ID: 16293190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E; Verolin M; Stensson A; Lycke N
    Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.
    Perry LL; Feilzer K; Caldwell HD
    J Immunol; 1997 Apr; 158(7):3344-52. PubMed ID: 9120292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis.
    Pal S; Peterson EM; de la Maza LM
    Vaccine; 2005 Nov; 23(46-47):5351-8. PubMed ID: 16085340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
    Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
    J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD; McClellan S; Kwon B; Barrett R
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa.
    Hawkins RA; Rank RG; Kelly KA
    Infect Immun; 2002 Sep; 70(9):5132-9. PubMed ID: 12183563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK; Aldwell FE; Beagley KW
    Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.
    Yang X; HayGlass KT; Brunham RC
    J Immunol; 1996 Jun; 156(11):4338-44. PubMed ID: 8666805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection.
    Chen L; Lei L; Chang X; Li Z; Lu C; Zhang X; Wu Y; Yeh IT; Zhong G
    J Immunol; 2010 Mar; 184(5):2602-10. PubMed ID: 20124098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.
    Johansson M; Schön K; Ward M; Lycke N
    Infect Immun; 1997 Mar; 65(3):1032-44. PubMed ID: 9038313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
    Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
    Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinfection of the mouse genital tract with Chlamydia trachomatis: the relationship of antibody to immunity.
    Tuffrey M; Falder P; Taylor-Robinson D
    Br J Exp Pathol; 1984 Feb; 65(1):51-8. PubMed ID: 6696831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H; Parnell M; Caldwell HD
    Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine model of ocular infection by a human biovar of Chlamydia trachomatis.
    Whittum-Hudson JA; O'Brien TP; Prendergast RA
    Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):1976-87. PubMed ID: 7657540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.
    Vicetti Miguel RD; Quispe Calla NE; Pavelko SD; Cherpes TL
    PLoS One; 2016; 11(9):e0162445. PubMed ID: 27606424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.